Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Investigative Ophthalmology and Visual Science

• Publication date

  1996-10-01

• Fields of study

  Medicine

• Identifiers
  PMID 8843916
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Control of experimental massive periretinal proliferation by daunomycin: dose-response relation

  2006cited by this paper
• An overview of glucocorticoid anti-inflammatory actions

  2005cited by this paper
• Improvement in efficacy of corticosteroid therapy in an animal model of proliferative vitreoretinopathy by pretreatment

  2005cited by this paper
• Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis.

  1995cited by this paper
• Treatment of Cytomegalovirus Retinitis With an Intraocular Sustained-Release Ganciclovir Implant: A Randomized Controlled Clinical Trial

  1994cited by this paper
• Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal implant for the sustained release of fluorouracil.

  1994cited by this paper
• Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial.

  1994cited by this paper
• Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR.

  1993cited by this paper
• Inflammatory cells in proliferative vitreoretinopathy subretinal membranes.

  1993cited by this paper
• Intravitreal sustained-release ganciclovir.

  1992cited by this paper
• Clearance of microsphere-entrapped 5-fluorouracil and cytosine arabinoside from the vitreous of primates

  1992cited by this paper
• Proliferative Vitreoretinopathy: Lymphocytes in Epiretinal Membranes

  1992cited by this paper
• Cytokines in proliferative vitreoretinopathy

  1991cited by this paper
• Microspheres of biodegradable polymers as a drug-delivery system in the vitreous.

  1991cited by this paper
• Further observations on the prevention of experimental proliferative vitreo-retinopathy by 5-fluorouracil.

  1991cited by this paper
• Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy

  1991cited by this paper
• Proliferative vitreoretinopathy (PVR): a personal account of its pathogenesis and treatment. Proctor lecture.

  1988influential reference
• Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA.

  1988cited by this paper
• Dexamethasone and indomethacin attenuate cryopexy. Induced breakdown of the blood-retinal barrier.

  1987cited by this paper
• Oral colchicine for the treatment of experimental traction retinal detachment.

  1986cited by this paper
• Clearance of intravitreal fluorouracil. Normal and aphakic vitrectomized eyes.

  1985cited by this paper
• Daunomycin in the treatment of experimental proliferative vitreoretinopathy. Effective doses in vitro and in vivo.

  1985cited by this paper
• Effects of cytotoxic drugs on proliferative vitreoretinopathy in the rabbit cell injection model.

  1984influential reference
• Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA.

  1984cited by this paper
• Prevention of experimental massive peri-retinal proliferation by 5-fluoro-uracil.

  1983cited by this paper
• Ocular toxicity of fluorouracil after vitrectomy.

  1983cited by this paper
• Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy.

  1983cited by this paper
• Fluorouracil for the treatment of massive periretinal proliferation.

  1982cited by this paper
• Experimental intraocular proliferation and neovascularization.

  1982cited by this paper
• Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide.

  1980cited by this paper
• Inhibition of intraocular proliferations with intravitreal corticosteroids.

  1980cited by this paper
• Changing concepts of failures after retinal detachment surgery.

  1979cited by this paper
• Intraocular penetration of subconjunctivally administered 14C-fluorouracil in rabbits.

  1979cited by this paper
• EFFECT OF STEROIDS ON GROWTH OF MOUSE FIBROBLASTS IN VITRO.

  1965cited by this paper

• Mutual Prodrugs - Codrugs.

  2022cites this paper
• A Prediction Model for the Intraocular Pharmacokinetics of Intravitreally Injected Drugs Based on Molecular Physicochemical Properties

  2019cites this paper
• Cytokine profiles of phakic and pseudophakic eyes with primary retinal detachment

  2018cites this paper
• Carnosic acid, Tangeretin, and Ginkgolide-B Anti-Neoplastic Cytotoxicity in Dual Combination with Dexamethasone-[anti-EGFR] in Pulmonary Adenocarcinoma (A549).

  2018cites this paper
• Advances in the use of prodrugs for drug delivery to the eye

  2017cites this paper
• Histopathological and ophthalmoscopic evaluation of apocynin on experimental proliferative vitreoretinopathy in rabbit eyes

  2017cites this paper
• Experimental Animal Models for Retinal and Choroidal Diseases

  2017influential citation
• Dexamethasone-(C21-phosphoramide)-[anti-EGFR]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency against pulmonary adenocarcinoma (A549)

  2016cites this paper
• Fluorinated steroids and their derivatives

  2016cites this paper
• Dexamethasone-( c 21-phosphoramide )-[ anti-egFr ] : molecular design , synthetic organic chemistry reactions , and antineoplastic cytotoxic potency against pulmonary adenocarcinoma ( a 549 )

  2016cites this paper
• The Study of Anti-Proliferative Effect of Intravitreal Implant in Surgical Treatment of Proliferative Vitreoretinopathy

  2016cites this paper
• A Novel Approach of Daunorubicin Application on Formation of Proliferative Retinopathy Using a Porous Silicon Controlled Delivery System: Pharmacodynamics.

  2015cites this paper
• IV.F. Pharmacotherapy of Proliferative Vitreoretinopathy

  2014cites this paper
• In Vitro Vitamin K3 Effect on Conjunctival Fibroblast Migration and Proliferation

  2014cites this paper
• Implants for drug delivery to the posterior segment of the eye: a focus on stimuli-responsive and tunable release systems.

  2014cites this paper
• Posterior Subtenon Triamcinolone Acetonide in Gas-filled Eyes as an Adjunctive Treatment for Complicated Proliferative Diabetic Retinopathy

  2013cites this paper
• Laser-induced intrachoroidal dexamethasone drug delivery system to posterior eye segment.

  2013cites this paper
• Pharmakologische Ansätze zur Behandlung der proliferativen Vitreoretinopathie

  2013cites this paper
• DIAGNOSTIC AND SURGICALTECHNIQUES

  2013cites this paper
• Pathophysiology of proliferative vitreoretinopathy in retinal detachment.

  2013influential citation
• Evaluation of 5-fluorouracil released from a foldable capsular vitreous body in vitro and in vivo

  2012cites this paper
• Inhibitory effect of three biopolymer materials on scar formation following trabeculectomy

  2011cites this paper
• Improving the Use of Drug Combinations Through the Codrug Approach

  2011cites this paper
• Inhibitory effect of biopolymer materials on scar formation following trabeculectomy.

  2011cites this paper
• OPIOID CODRUGS FOR PAIN MANAGEMENT

  2011cites this paper
• Biodegradable Intraocular Therapies for Retinal Disorders

  2010cites this paper
• Inhibitory Effect of Epigallocatechin Gallate (EGCG), Resveratrol, and Curcumin on Proliferation of Human Retinal Pigment Epithelial Cells In Vitro

  2010cites this paper
• Codrug: an efficient approach for drug optimization.

  2010cites this paper
• Investigation of Kinetics of Methotrexate for Therapeutic Treatment of Intraocular Lymphoma

  2010cites this paper
• Steroids and the Management of Macular Edema

  2010cites this paper
• Intraocular Sustained-Release Delivery Systems for Triamcinolone Acetonide

  2009cites this paper
• Current trends of intravitreal steroid use in retinal diseases.

  2009cites this paper
• Intravitreal steroid versus macular laser for treatment of diabetic macular edema

  2009cites this paper
• Intravitreal steroids for macular edema: the past, the present, and the future.

  2008cites this paper
• Scope and limitations of the co-drug approach to topical drug delivery.

  2008cites this paper
• Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial.

  2008cites this paper
• [Possible role of alkylphosphocholines in retinal reattachment surgery].

  2007cites this paper
• Codrugs: Potential Therapies for Dermatological Diseases

  2007cites this paper
• Mögliche Rolle von Alkylphosphocholinen bei der Ablatio-Chirurgie

  2007cites this paper
• Approcci farmacologici per migliorare il risultato chirurgico dopo riaccollamento retinico

  2006cites this paper
• Corticosteroids as antiangiogenic agents.

  2006cites this paper
• Ocular drug delivery

  2006cites this paper
• Chapter 132 – The Mechanism of Action of Drugs for the Treatment of Vitreoretinal Scarring

  2006cites this paper
• Effects of daunorubicin, mitomycin C, azathioprine and cyclosporin A on human retinal pigmented epithelial, corneal endothelial and conjunctival cell lines

  2006cites this paper
• Chemotherapeutische Nebenwirkungen im Augenbereich

  2005cites this paper
• Pharmacokinetics of intravitreal 5-fluorouracil prodrugs in silicone oil: experimental studies in pigs.

  2005cites this paper
• Sinnhaftigkeit der systemischen Steroidgabe nach vitreoretinalen Eingriffen und Plombenchirurgie

  2005cites this paper
• Pharmacological Approaches to Improve Surgical Outcomes After Retinal Reattachment Surgery

  2005cites this paper
• Unexplained head tilt following surgical treatment of congenital esotropia: a postural manifestation of dissociated vertical divergence

  2004cites this paper
• Mixed infection (Pseudomonas and coagulase negative staphylococci) microbial keratitis associated with extended wear silicone hydrogel contact lens

  2004cites this paper
• Long term efficacy and safety of botulinum toxin A injection for

  2004cites this paper
• Novel approaches to ocular drug delivery.

  2004cites this paper
• Adjunctive Therapies for Proliferative Vitreoretinopathy

  2004cites this paper
• Intravitreales Triamcinolonacetonid zur Behandlung intraokulärer ödematöser und neovaskulärer Erkrankungen

  2004cites this paper
• [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].

  2004cites this paper
• Oftalmolojide Kullanılan Deneysel Hayvan Modelleri

  2004cites this paper
• Corticosteroids in posterior segment disease: an update on new delivery systems and new indications

  2004cites this paper
• An intravitreal biodegradable sustained release naproxen and 5-fluorouracil system for the treatment of experimental post-traumatic proliferative vitreoretinopathy

  2004cites this paper
• Long term efficacy and safety of botulinum toxin A injection for

  2004cites this paper
• Long term efficacy and safety of botulinum toxin A injection for

  2004cites this paper
• Long term efficacy and safety of botulinum toxin A injection for

  2004cites this paper
• Long term efficacy and safety of botulinum toxin A injection for

  2004cites this paper
• Long term efficacy and safety of botulinum toxin A injection for

  2004cites this paper
• Long term efficacy and safety of botulinum toxin A injection for

  2004cites this paper
• Long term efficacy and safety of botulinum toxin A injection for

  2004cites this paper
• Long term efficacy and safety of botulinum toxin A injection for

  2004cites this paper
• IL-10 in vivo gene expression in a cell-induced animal model of proliferative vitreoretinopathy.

  2003cites this paper
• [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].

  2003cites this paper
• Lentivirus-mediated expression of angiostatin efficiently inhibits neovascularization in a murine proliferative retinopathy model

  2003cites this paper
• Intraocular pressure after intravitreal injection of triamcinolone acetonide

  2003cites this paper
• Intravitreal crystalline triamcinolone acetonide as an additional tool in pars plana vitrectomy for complicated proliferative vitreoretinopathy?

  2003cites this paper
• Intravitreal triamcinolone acetonide for exudative age related macular degeneration

  2003cites this paper
• Fluorouracil prodrugs for the treatment of proliferative vitreoretinopathy: formulation in silicone oil and in vitro release of fluorouracil.

  2003cites this paper
• Therapie intraokulärer, ödematöser, proliferativer und neovaskulärer Erkrankungen durch intravitreales Triamcinolon-Acetonid

  2003cites this paper
• Novel approaches for retinal drug delivery.

  2002cites this paper
• Synthesis, pharmacokinetics, efficacy, and rat retinal toxicity of a novel mitomycin C-triamcinolone acetonide conjugate.

  2002cites this paper
• Mechanisms in proliferative vitreoretinopathy.

  2002cites this paper
• Comparison of fibroblast inhibitory effect of α-tocopherol succinate and 13-cis retinol

  2002cites this paper
• Intravitreale Injektion von kristallinem Triamcinolon Acetonid als Therapie des diffusen diabetischen Makulaödems

  2002cites this paper
• Synthesis and release of 5-fluorouracil from poly(N-vinylpyrrolidinone) bearing 5-fluorouracil derivatives.

  2002cites this paper
• [Intravitreal injection of crystalline triamcinolone acetonide in the treatment of diffuse diabetic macular oedema].

  2002cites this paper
• Pathogenesis and Surgical Management of Common Geriatric Ophthalmic Disorders

  2001cites this paper
• Enhancement of scleral macromolecular permeability with prostaglandins.

  2001cites this paper
• Synthesis of allyloxycarbonyloxymethyl-5-fluorouracil and copolymerizations with N-vinylpyrrolidinone

  2000cites this paper
• Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device.

  2000cites this paper
• PHARMACOKINETICS OF THE FLUOCINOLONE/5‐FLUOROURACIL CODRUG IN THE GAS‐FILLED EYE

  2000cites this paper
• Combined Pharmacologic Therapy in a Rabbit Model of Proliferative Vitreoretinopathy (PVR)

  2000cites this paper
• Biomaterials used in the posterior segment of the eye.

  2000cites this paper
• TREATMENT OF RETINAL DISEASE IN THE NEW MILLENNIUM

  1999cites this paper
• Development of a multiple-drug delivery implant for intraocular management of proliferative vitreoretinopathy.

  1998cites this paper
• Proliferative vitreoretinopathy: an overview.

  1998cites this paper
• An intravitreal sustained-release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy.

  1998cites this paper
• Antiproliferative effect of intravitreal alpha-tocopherol and alpha-tocopheryl-acid-succinate in a rabbit model of PVR.

  1997cites this paper